Participation of a Gaba-Ergic System in the Processes of Neuroimmunomodulation

References

• Aznauryan A. V., Shekoyan V. A., Frangulyan L. A., Tumanyan E., Shekoyan E. C. Morphofunctional changes in immune organs under influence of GABA-ergic drugs. Neurohumoral regulation of immune homeostasis. Leningrad 1986; 93–94
   Google Scholar
• Belokrylov G. A., Molchanova I. Y. Immunostimulating property of GABA. Bulletin of Experimental Biology & Medicine 1987; 9: 345–346
   Google Scholar
• Brondz B. D. In vitro & in vivo study of cytotoxic effect of cellular & humoral isoantibodies. II. Interaction of immune lymphocytes with cells of normal & tumour homologic tissues. Questions of Oncology 1964; 10: 64–71, N 8
   Google Scholar
• Cantor H., Boyse E. A. Lymphocytes as models for the study of mammalian cellular differentiation. Immunological Reviews 1977; 33: 105
   PubMed Web of Science ®Google Scholar
• Curtis D. R., Duggan A. W., Felix D., Johnston G. A. R. Bicuculline an antagonist of GABA & synaptic inhibition in the spinal cord. Brain Research 1971; 32: 69–96
   PubMed Web of Science ®Google Scholar
• Davies J., Watkins J. C. The action of -phenyl-GABA derivatives on neurons of the cat cerebral cortex. Brain Research 1974; 70: 501–505
   PubMed Web of Science ®Google Scholar
• Descotes J., Tedone R., Evreux J. C. Suppression of humoral & cellular immunity in normal mice by diazepam. Immunology Letters 1981; 3–4: 199–205
   Google Scholar
• Devoino L. V., Alperina E. L. Immune response stimulation by activation of dopaminergicsystem interaction with serotoninergic system neuroimmunomodulation. Neuroimmunomodulation, N. H. Spector, 1985; 124–129
   Google Scholar
• Bethesda Maryland, Devoino L., Eliseeva L., Eremina O., Idova G., Cheido M. 5-hydroxytryptophan effect on the development on the immune response: IgM & IgG-antibodies & rosette-formation in primary & secondary responses. European Journal of Immunology 1975; 5: 394–399
   Google Scholar
• Devoino L. V., Eremina O. F. Influence of pituitary stalk dissection & nuclei raphe lesion on the antibody production in rabbits. Setchenov Psysiological Journal of USSR 1977; 63: 374–377
   PubMedGoogle Scholar
• Devoino L. V., Ilyuchenok R. Y. Monominergic system in the control of immune response (serotonin, dopamine). Nauka, Novosibirsk 1983
   Google Scholar
• Didier M., Belin M. F., Aguera M., Buda M., Pujol J. F. Pharmacological effects of GABA on serotonin metabolism in the rat brain. Neurochemistry International 1985; 7: 481–489, N 3
   PubMedGoogle Scholar
• Duff D. M., Dille J. M. Distribution & rate of elimination of picrotoxin. The Journal of Pharmacology & Experimental Therapeutics 1939; 67: 353–357
   Google Scholar
• Enna S. J., Maggi A. Biochemical pharmacology of GABA-ergic agonists. Life Sciences 1979; 24: 1727–1738
   PubMedGoogle Scholar
• Erdo S. L., Kiss R., Szporny L. Comparative characterization of glutamate decarboxylase in crude homogenates of oviduct, ovary & hypothalamus. Journal ofNeurochemistry 1984; 43: 1532–1537
   PubMedGoogle Scholar
• Forchetti C. M., Meek J. L. Evidence for a tonic GABA-ergic control of serotonin neurons in the median raphe nucleus. Brain Research 1981; 206: 208–212
   PubMedGoogle Scholar
• Frangulyan L. A., Manukyan R. A., Babayan N. P., Danelyan G. T., Bagdasaryan G. H., Armenyan N. M. Influence of neuroactive aminoacids on some indexes of natural immunity. Neurohumoral regulation of immune homeostasis. Leningrad. 1986; 122–123
   Google Scholar
• Graves P. M., Wilson C. J., Young S. J., Rebec G. V. Self-inhibition by dopaminergic neurons. Science 1975; 190: 522–529
   PubMedGoogle Scholar
• Haefely W. The biological basis of benzodiazepine actions. Journal of Psychoactive Drugs 1983; 15: 19–39, N 1–2
   PubMed Web of Science ®Google Scholar
• Haefely W. Benzodiazepines. Mechanisms of action. Antiepileptic Drugs, Third Edition, R. Levy, R. Mattson, B. Meldrum, J. K. Pemy, F. E. Dreifuss, 1989; 721–734
   Google Scholar
• Krogsgaard-Larsen P., Falch E., Jacobsen P. GABA agonists: structural requirements for interaction with the GABAbenzodiazepine receptor complex. Actions & interactions of GABA & benzodiazepines, N. G. Bowery. Raven Press, New York 1984; 109–132
   Google Scholar
• Makara G. B., Stark E. Role of GABA in the hypothalamic control of the pituitary gland. Interaction between putative neurotransmitters in the brain, S. Garattini, J. F. Pujol, R. Samanin. Raven Press, New York 1978; 263–283
   Google Scholar
• Marcucci R., Guaitani A., Kvetina J., Mussini E., Garattini S. Species difference in diazepam metabolism & anticonvulsant effect. European Journal of Pharmacology 1968; 4: 467–470
   PubMed Web of Science ®Google Scholar
• Möhler H., Okada T. GABA receptor binding with H(+)-bicuculline methiodide in rat CNS. Nature 1977; 267: 65–67
   PubMed Web of Science ®Google Scholar
• Miiller-Oerlinghausen B. Klinische pharmacologic der benzodiazepine. Medizinische Welt 1985; 36: 1191–1194, N 38
   Google Scholar
• Piriči D., Maney H., Boranid M., Poliak-Blazi M., Lakid N. Effect of diazepam on brain neurotransmitters, plasma corticosterone, and immune system of stressed rats. Annals of New York Academy of Sciences 1987; 496: 450–458
   PubMedGoogle Scholar
• Racagni G., Apud J. A., Civati C., Cocchi D., Casanueva F., Locatelli V., Nistico G., Muller E. E. Neurochemical aspects of GABA and glutamate in the hypothalamo-pituitary system. GABA and benzodiazepine receptors, E. Costa, G. Di Chiara, G. L. Gessa. Raven Press, New York 1981; 261–271
   Google Scholar
• Ratnikov V. I., Ryabinina N. E., Ostrovskaya R. U. Influence of GABA-ergic drugs on humoral immune response. Bulletin of Experimental Biology & Medicine 1982; 94: 56–58, N 10
   Google Scholar
• Rooyen J. M. V., Offermeier J. Pharmaco-kinetics of the benzodiazepines. South African Medical Journal 1985; 68: 10–13, Suppl.
   Google Scholar
• Scatton B., Serrano A., Rivot J. P., Nishikawa T. Inhibitory GABAergic influence on striatal serotoninergic transmission exerted in the dorsal raphe as revealed by in vivo voltammetry. Brain Research 1984; 305: 343–352
   PubMedGoogle Scholar
• Sopotsynskaya E. B., Lisnyak I. A., Yakimenko V. A. Change of immunologic reactivity of organism & content of monoamindicarbonic acids & their derivates in brain & spleen. Ukrainian Biochemical Journal 1980; 52: 434–440
   Google Scholar
• Ticku M. K. Benzodiazepine-GABA receptor–ionophore complex. Current concepts. Neuropharmacology 1983; 22B: 1459–1470
   Google Scholar
• Ticku M. K., Olsen R. W. Picrotoxin binding sites in brain. Brain receptor methodologies, P. J. Marangos, I. C. Campbell, R. M. Cohen, 1984; 211–229, Part B. Amino acid, peptides, psychoactive drugs
   Google Scholar
• Valin A., Brijere P., Naquet R. Convulsant effect of Ro 5–4864, a peripheral tipe benzodiazepine, on the baboon (papio papio). Neuroscience Letters 1986; 66: 210–214
   PubMedGoogle Scholar
• Waszozak B. L., End N., Walters J. R. Effects of muscimol & picrotoxin on single unit activity of substantia nigra neurons. Brain Research 1980; 188: 185–197
   PubMedGoogle Scholar
• Weber R. J. Characterization & distribution of “Peripheral Type” benzodiazepine receptors on cells of the immune system. Neuroimmunomodulation, N. H. Spector. Maryland, Bethesda 1985; 48–49
   Google Scholar
• Wofsy D., Mayes D. C., Woodcock J., Seaman W. E. Inhibition of humoral immunity in vivo by monoclonal antibody to L3T4 studies with soluble antigens in intact mice. Journal of Immunology 1985; 135: 1698–1706
   PubMed Web of Science ®Google Scholar
• Wood P. L., Etienne P., Lai S., Nair N. P. V. GABAergic regulation of nigrastriatal neurons: coupling of benzodiazepine & GABA receptors. Progress in Neuropsychopharmacology & biological Psychiatry 1982; 6: 471–474, N 4–6
   PubMedGoogle Scholar
• Zavala F., Lenfant M. Benzodiazepines & PK 11195. Exert immunomodulating activities by binding on a specific receptor on macrophages. Annals of The New York Academy of Sciences 1987; 496: 240–249
   PubMedGoogle Scholar